Impact of chemoradiotherapy (CRT) on local control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP 07 study.
Florence Huguet
Consultant or Advisory Role - Merck Serono
Honoraria - Roche/Genentech
Pascal Hammel
Consultant or Advisory Role - Roche
Dewi Vernerey
No relevant relationships to disclose
David Goldstein
No relevant relationships to disclose
Jean Luc Van Laethem
No relevant relationships to disclose
Bengt Glimelius
No relevant relationships to disclose
Nigel Spry
No relevant relationships to disclose
Sophie Paget-Bailly
No relevant relationships to disclose
Franck Bonnetain
Consultant or Advisory Role - Invectys
Honoraria - Bristol-Myers Squibb; Merck Serono; Nestlé
Research Funding - Roche
Christophe Louvet
No relevant relationships to disclose